David Harel

CytoReason Ltd. is an Israeli company that aims to link mechanisms across diseases, treatments, and patient groups. The company is based in Tel Aviv-Yafo, Israel. The company provides a platform that connects decisions to the underlying science of drug programs. The company's team includes top immunologists, a chief medical officer, a chief data scientist, a VP of strategic alliances, a chief technology officer, and a head of commercial operations. The company focuses on immune-mediated diseases such as inflammatory bowel disease, atopic dermatitis, rheumatoid arthritis, and asthma, immuno-oncology diseases such as non-small cell lung cancer, renal cell carcinoma, and melanoma, and fibrosis diseases such as non-alcoholic steatohepatitis, systemic sclerosis, and idiopathic pulmonary fibrosis. CytoReason was founded in 2016 by Elina Starosvetsky, Ksenya Kveler, Yuval Kalugny, Renaud Gaujoux, David Harel, and Shai Shen-Orr. David Harel has been the CEO since 2016.

I-Logix, Inc. developed system design software & solutions. These solutions allowed engineers to graphically model requirements, behavior and functionality of embedded systems. The company was co-founded by Dr. David Harel in 1987 and was headquartered in Andover, MA

Virtual OfficeWare LLC provides software solutions to physicians. It offers a platform of clinical and business performance products including GE Centricity Practice Management and Electronic Health Records as well as integrated auxiliary solutions. The firm also provides personalized implementation, training, support, hosting, and customized programming and reports. The company was founded by Gary Cindrich and Looney Jerry in 2000 and is headquartered in Pittsburgh, PA.